FDA moves to end chlorinated-solvent use in color additives, by two different routes
Two companion final orders remove three chlorinated solvents from colour-additive rules — one on the cancer-based Delaney Clause, the other because industry had abandoned the uses. Effective 11 January 2027.
The Food and Drug Administration has acted to end the authorised use of three chlorinated solvents in colour additives, but it did so in two separate final orders resting on two different legal grounds. Both were published in the Federal Register on 10 November 2026 and both take effect on 11 January 2027 [s1][s2]. The split is not a technicality — it turns on a distinction, written into the statute, between a colour additive itself and an impurity left behind in one.
The three solvents are ethylene dichloride (CAS No. 107-06-2), methylene chloride (CAS No. 75-09-2), and trichloroethylene (CAS No. 79-01-6) [s1]. FDA states in the orders that all three have been found to induce cancer in animals, citing studies sponsored by the National Toxicology Program [s1].
The Delaney order
The first order responds to a petition filed by the Environmental Defense Fund together with several other groups, which FDA announced it had accepted in January 2024 [s1]. The petitioners asked the agency to remove all uses of the three solvents from four colour-additive regulations, arguing the substances are unsafe under the Delaney Clause — the provision of the Federal Food, Drug, and Cosmetic Act that deems a colour additive unsafe, as a matter of law, if it is found to induce cancer in people or animals [s1].
FDA granted part of that request. It is amending 21 CFR 73.1 to remove the authorised use of methylene chloride as a diluent in colour-additive mixtures in inks used for marking fruit and vegetables [s1]. Because a diluent is intentionally mixed into a colour-additive mixture, the agency concluded it is regulated as a colour additive and is therefore subject to the Delaney Clause [s1]. Once that applies, FDA says, the ban follows automatically: the clause "prevents FDA from finding the color additive uses of these solvents to be safe if the solvents have been found to induce cancer in animals, regardless of the probability, or risk, of cancer" from the use [s1].
The agency denied the rest of that petition. The same three solvents are also authorised as food-grade extractants used to manufacture three colours — annatto extract (21 CFR 73.30), paprika oleoresin (21 CFR 73.345), and turmeric oleoresin (21 CFR 73.615) [s1]. There, FDA reasoned, the solvent is not itself a colour additive; any solvent left in the finished colour is a residue, and therefore an impurity [s1]. The Delaney Clause, the agency notes, applies to the additive itself and not to impurities in it, so it could not grant the petition's request on Delaney grounds for those uses [s1]. The relevant regulations cap total chlorinated-solvent residues in those colours at 30 parts per million [s1].
The abandonment order
That left the extraction-solvent uses untouched by the first order — and the second order closes them, on entirely different reasoning. It responds to a petition from the International Association of Color Manufacturers, the trade group for colour makers, which asked FDA to remove the same uses on the basis of abandonment: the industry told the agency the uses had been permanently abandoned and provided data to that effect [s2]. FDA granted that request, amending the regulations to drop ethylene dichloride, methylene chloride, and trichloroethylene as authorised extraction solvents for annatto extract, paprika oleoresin, and turmeric oleoresin [s2].
The two orders are explicitly linked. The abandonment order denies as moot the manufacturers' request to also remove the ink-diluent use of methylene chloride, because that use had already been removed under the Delaney Clause in the companion order [s2]. Read together, the pair removes every authorised use of the three solvents across the four regulations — one use on cancer grounds, the others because they are no longer used.
Why the route matters
The distinction FDA draws is the practical heart of the action. Abandonment removes a listing because no one relies on it any more; it is a regulatory clean-up that says nothing new about safety. The Delaney Clause is a safety provision, and it is absolute by design — courts have held it to be, in the agency's phrase, "extraordinarily rigid," applying without regard to how small the estimated risk is [s1]. By granting the ink-diluent removal on Delaney grounds and the extraction uses on abandonment, FDA both reached the same end point for all three solvents and kept the legal bases separate, which governs how each removal could be challenged.
The orders carry an objection window. Interested parties may file objections and requests for a hearing by 10 December 2026, and FDA says that if any provision is delayed or stayed by proper objections it will publish notice in the Federal Register [s1][s2]. That is the mechanism by which the 11 January 2027 effective date could slip for part of either order.
What it does and does not say
What is settled is specific: two dated final orders exist, they remove the authorised colour- additive uses of three solvents found to cause cancer in animals, and absent a stay they are effective 11 January 2027 [s1][s2]. What the orders do not claim is a new finding of consumer harm. FDA responded to comments raising the solvents' regulation in other countries and by the Environmental Protection Agency by saying its decisions rest on its own assessments under US law, and that each agency regulates uses under its own authority [s1]. The extraction-solvent uses, in particular, were removed because industry had abandoned them, not because the agency concluded a residue at the permitted limit was unsafe [s1][s2].
Sources
- Color Additive Petition From Environmental Defense Fund et al.; Request To Amend the Color Additive Regulations To Remove the Solvents Ethylene Dichloride, Methylene Chloride, and Trichloroethylene (Final amendment; order; notification of partial denial of petition) — U.S. Food and Drug Administration / Federal Register , November 10, 2026
- Color Additive Petition From the International Association of Color Manufacturers; Request To Amend the Color Additive Regulations To Remove the Solvents Methylene Chloride, Trichloroethylene, and Ethylene Dichloride (Final amendment; order; notification of partial denial of petition) — U.S. Food and Drug Administration / Federal Register , November 10, 2026
FDA is pulling two old food dyes - but for disuse, not on safety grounds
The agency revoked Orange B and proposed dropping Citrus Red No. 2 because neither has been used in decades. It said the safety of synthetic colours is outside the scope of these orders.
FDA proposes new infant formula limits for iodine, vitamin A, D and manganese
A proposed rule under Operation Stork Speed would revise minimum and maximum levels of four of the 30 required infant formula nutrients and set a first ceiling for manganese. Comments close 2 March 2027.
FDA adds a chemical-hazards chapter to its food-safety guidance
A new draft Chapter 12 explains how food manufacturers should control chemical hazards under the FSMA preventive-controls rule. It joins a multichapter guidance built since 2016; comments close 21 January 2027.
FDA proposes cadmium action levels for baby and toddler foods
A draft guidance would set the first cadmium action levels for processed foods for children under two — from 10 parts per billion for most fruits and vegetables to 45 for dry infant cereals. Comments close 22 December.